BOOSTER RESPONSE TO RECOMBINANT YEAST-DERIVED HEPATITIS-B VACCINE IN VACCINEES WHOSE ANTI-HBS RESPONSES WERE INITIALLY ELICITED BY A PLASMA-DERIVED VACCINE

被引：8
|
作者：
CHAN, CY [1 ]
LEE, SD [1 ]
TSAI, YT [1 ]
LO, KJ [1 ]
机构：
[1] VET GEN HOSP,DEPT MED,DIV GASTROENTEROL,TAIPEI 11217,TAIWAN
来源：
VACCINE | 1991年 / 9卷 / 10期
关键词：
BOOSTER RESPONSE; PLASMA-DERIVED HEPATITIS-B VACCINE; RECOMBINANT YEAST-DERIVED VACCINE;
D O I：
10.1016/0264-410X(91)90294-G
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
One hundred and eight primary school students who had been vaccinated with three doses of a plasma-derived hepatitis B vaccine were randomly divided into two groups, to receive a booster dose of either the same vaccine or of a recombinant yeast-derived vaccine. The pre-booster anti-hepatitis B surface antigen (HBs) geometric mean titres (GMT) were similar in both groups (281.8 mIU ml-1 versus 295.1 mIU ml-1, p > 0.5). One month after booster vaccination, all the vaccinees in both groups had a marked elevation in their anti-HBs titres, the anti-HBs GMT in group 1 and group 2 being 19 952.6 and 51 286.1 mIU ml-1 (p < 0.05), respectively. In conclusion, the recombinant yeast-derived hepatitis B vaccine was able to elicit an excellent booster response in vaccinees who had originally received a plasma-derived vaccine.
引用
收藏
页码：765 / 767
页数：3
相关论文
共 50 条
  • [31] COST OF PLASMA-DERIVED HEPATITIS-B VACCINE PRODUCTION
    MAHONEY, RT
    VACCINE, 1990, 8 (04) : 397 - 401
  • [32] IMMUNOGENICITY AND SAFETY OF RECOMBINANT YEAST-DERIVED HEPATITIS-B VACCINE IN HEMODIALYSIS-PATIENTS
    FUJIYAMA, S
    YOSHIDA, K
    SATO, T
    SHIMADA, H
    DEGUCHI, T
    HEPATO-GASTROENTEROLOGY, 1990, 37 : 140 - 144
  • [33] Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines
    Heijtink, RA
    van Bergen, P
    Paulij, WP
    de Man, RA
    Osterhaus, ADME
    VACCINE, 2000, 18 (15) : 1531 - 1538
  • [34] Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results
    Van Herck, K
    Van Damme, P
    Thoelen, S
    Meheus, A
    VACCINE, 1998, 16 (20) : 1933 - 1935
  • [35] IMMUNIZATION AGAINST HEPATITIS-B - COMPARISON BETWEEN PLASMA-DERIVED AND YEAST-DERIVED VACCINES
    OLIVEIRA, PM
    FERRAZ, ML
    CASTILHO, MP
    KEMP, VL
    SILVA, AE
    HEPATOLOGY, 1994, 19 (04) : I112 - I112
  • [36] ANTIBODY-RESPONSES TO RECOMBINANT, YEAST-DERIVED HEPATITIS-B VACCINE IN TEENAGE NEW-ZEALAND CHILDREN
    MILNE, A
    MOYES, CD
    ALLWOOD, GK
    PEARCE, NE
    KRUGMAN, S
    NEW ZEALAND MEDICAL JOURNAL, 1988, 101 (840) : 67 - 69
  • [37] IMMUNOGENICITY AND TOLERANCE OF A YEAST-DERIVED HEPATITIS-B VACCINE IN HOMOSEXUAL MEN
    PRINSEN, H
    GOILAV, C
    SAFARY, A
    ANDRE, FE
    PIOT, P
    POSTGRADUATE MEDICAL JOURNAL, 1987, 63 : 147 - 150
  • [38] REACTOGENICITY AND IMMUNOGENICITY OF A RECOMBINANT HEPATITIS-B VACCINE COMPARED WITH A PLASMA-DERIVED VACCINE IN YOUNG-ADULTS
    JUST, M
    BERGER, R
    JUST, V
    POSTGRADUATE MEDICAL JOURNAL, 1987, 63 : 121 - 123
  • [39] IMMUNOGENICITY OF A YEAST-DERIVED HEPATITIS-B VACCINE IN HEMODIALYSIS-PATIENTS
    BRUGUERA, M
    CREMADES, M
    RODICIO, JL
    ALCAZAR, JM
    OLIVER, A
    DELRIO, G
    ESTEBANMUR, R
    AMERICAN JOURNAL OF MEDICINE, 1989, 87 (3A): : S30 - S32
  • [40] DRUGS RECENTLY RELEASED IN BELGIUM - RECOMBINANT DNA YEAST-DERIVED HEPATITIS-B VACCINE TERAZOSIN
    HARVENGT, C
    ACTA CLINICA BELGICA, 1988, 43 (02): : 163 - 165
12345